Venn Life Sciences

CRO Venn Life Sciences inks €2.5m deal

09-Nov-2016 By Melissa Fassbender

Venn Life Sciences has signed a new contract with Sedana Medical AB worth €2.5m as the CRO continues to reposition itself for growth.

Venn Life Sciences eyes continued growth after 'impressive hike' in revenues

03-Oct-2016 By Melissa Fassbender

With several systems and process improvement initiatives underway, the growing contract research organization (CRO), Venn Life Sciences, continues to look for earnings enhancing opportunities, says CEO.

Growing CRO eyes further expansion

03-Aug-2016 By Melissa Fassbender

With a new contract signed worth €2.8m ($3.13m), the growing contract research organization (CRO), Venn Life Sciences, is eyeing future expansion.

Venn acquires part of French CRO for about €500k

12-Aug-2014 By Zachary Brennan

In its third acquisition in the past 10 months, European CRO (contract research organization) Venn Life Sciences has acquired Cardinal Systems, a France-based CRO specialising in data management and randomisation systems.

Venn buys human skin substitute

04-Mar-2014 By Fiona BARRY

Clinical research group Venn Life Sciences has acquired the rights to LabSkin (pictured), a human skin substitute that behaves like the real thing, from dermatology CRO Evocutis.

Venn acquires German CRO and says there's more to come

18-Nov-2013 By Dan Stanton

Venn Life Sciences has broadened its global footprint with the acquisition of a German CRO and says it is looking for more growth opportunities.

Venn Life Sciences & Encorium to merge, add working capital

20-Feb-2012

CROs Venn Life Sciences and Encorium are to merge and have secured working capital to expand the business.